Breaking the link between prescription drug list prices and compensation to middlemen like pharmacy benefit managers (PBMs) ...

The Patented Medicine Prices Review Board’s mandate is to make sure that drug prices are not excessive. However, new ...

The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump ...

A direct-to-consumer program for its drugs could bring down higher U.S. drug prices while cutting out pharmacy benefit managers.

Health policy researcher Geoffrey Joyce argues that only delinking compensation from the list price of a drug will lower drug spending.

Breaking News Live Updates: Parliament adjourned till Monday amid ruckus by Opposition on 5th day of monsoon session.